Literature DB >> 35918105

Rituximab in the Frail and Elderly with Severe ANCA-Associated GN.

Silke R Brix1,2, Vladimir Tesař3.   

Abstract

Entities:  

Keywords:  ANCA; glomerulonephritis; rituximab

Year:  2022        PMID： 35918105      PMCID： PMC9528265          DOI： 10.2215/CJN.04760422

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   10.614


× No keyword cloud information.
  10 in total

1.  Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.

Authors:  Rachel B Jones; Jan Willem Cohen Tervaert; Thomas Hauser; Raashid Luqmani; Matthew D Morgan; Chen Au Peh; Caroline O Savage; Mårten Segelmark; Vladimir Tesar; Pieter van Paassen; Dorothy Walsh; Michael Walsh; Kerstin Westman; David R W Jayne
Journal:  N Engl J Med       Date:  2010-07-15       Impact factor: 91.245

2.  Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.

Authors:  Michael Walsh; Peter A Merkel; Chen-Au Peh; Wladimir M Szpirt; Xavier Puéchal; Shouichi Fujimoto; Carmel M Hawley; Nader Khalidi; Oliver Floßmann; Ron Wald; Louis P Girard; Adeera Levin; Gina Gregorini; Lorraine Harper; William F Clark; Christian Pagnoux; Ulrich Specks; Lucy Smyth; Vladimir Tesar; Toshiko Ito-Ihara; Janak Rashme de Zoysa; Wojciech Szczeklik; Luis Felipe Flores-Suárez; Simon Carette; Loïc Guillevin; Charles D Pusey; Alina L Casian; Biljana Brezina; Andrea Mazzetti; Carol A McAlear; Elizabeth Broadhurst; Donna Reidlinger; Samir Mehta; Natalie Ives; David R W Jayne
Journal:  N Engl J Med       Date:  2020-02-13       Impact factor: 91.245

3.  Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized Trial.

Authors:  Pierre Charles; Élodie Perrodeau; Maxime Samson; Bernard Bonnotte; Antoine Néel; Christian Agard; Antoine Huart; Alexandre Karras; François Lifermann; Pascal Godmer; Pascal Cohen; Catherine Hanrotel-Saliou; Nicolas Martin-Silva; Grégory Pugnet; François Maurier; Jean Sibilia; Pierre-Louis Carron; Pierre Gobert; Nadine Meaux-Ruault; Thomas Le Gallou; Stéphane Vinzio; Jean-François Viallard; Eric Hachulla; Christine Vinter; Xavier Puéchal; Benjamin Terrier; Philippe Ravaud; Luc Mouthon; Loïc Guillevin
Journal:  Ann Intern Med       Date:  2020-06-02       Impact factor: 25.391

4.  Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis.

Authors:  Loïc Guillevin; Christian Pagnoux; Alexandre Karras; Chahera Khouatra; Olivier Aumaître; Pascal Cohen; François Maurier; Olivier Decaux; Jacques Ninet; Pierre Gobert; Thomas Quémeneur; Claire Blanchard-Delaunay; Pascal Godmer; Xavier Puéchal; Pierre-Louis Carron; Pierre-Yves Hatron; Nicolas Limal; Mohamed Hamidou; Maize Ducret; Eric Daugas; Thomas Papo; Bernard Bonnotte; Alfred Mahr; Philippe Ravaud; Luc Mouthon
Journal:  N Engl J Med       Date:  2014-11-06       Impact factor: 91.245

5.  Avacopan for the Treatment of ANCA-Associated Vasculitis.

Authors:  David R W Jayne; Peter A Merkel; Thomas J Schall; Pirow Bekker
Journal:  N Engl J Med       Date:  2021-02-18       Impact factor: 91.245

6.  Kidney Histopathology Can Predict Kidney Function in ANCA-Associated Vasculitides with Acute Kidney Injury Treated with Plasma Exchanges.

Authors:  Dorian Nezam; Raphaël Porcher; François Grolleau; Pauline Morel; Dimitri Titeca-Beauport; Stanislas Faguer; Alexandre Karras; Justine Solignac; Noémie Jourde-Chiche; François Maurier; Hamza Sakhi; Khalil El Karoui; Rafik Mesbah; Pierre Louis Carron; Vincent Audard; Didier Ducloux; Romain Paule; Jean-François Augusto; Julien Aniort; Aurélien Tiple; Cédric Rafat; Séverine Beaudreuil; Xavier Puéchal; Pierre Gobert; Ziad Massy; Catherine Hanrotel; Stéphane Bally; Nihal Martis; Cécile-Audrey Durel; Geoffroy Desbuissons; Pascal Godmer; Aurélie Hummel; François Perrin; Antoine Néel; Claire De Moreuil; Tiphaine Goulenok; Dominique Guerrot; Steven Grange; Aurélie Foucher; Alban Deroux; Carole Cordonnier; Céline Guilbeau-Frugier; Anne Modesto-Segonds; Dominique Nochy; Laurent Daniel; Anissa Moktefi; Marion Rabant; Loïc Guillevin; Alexis Régent; Benjamin Terrier
Journal:  J Am Soc Nephrol       Date:  2022-01-24       Impact factor: 10.121

7.  Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2).

Authors:  Pierre Charles; Benjamin Terrier; Élodie Perrodeau; Pascal Cohen; Stanislas Faguer; Antoine Huart; Mohamed Hamidou; Christian Agard; Bernard Bonnotte; Maxime Samson; Alexandre Karras; Noémie Jourde-Chiche; François Lifermann; Pierre Gobert; Catherine Hanrotel-Saliou; Pascal Godmer; Nicolas Martin-Silva; Grégory Pugnet; Marie Matignon; Olivier Aumaitre; Jean-François Viallard; François Maurier; Nadine Meaux-Ruault; Sophie Rivière; Jean Sibilia; Xavier Puéchal; Philippe Ravaud; Luc Mouthon; Loïc Guillevin
Journal:  Ann Rheum Dis       Date:  2018-04-25       Impact factor: 19.103

8.  Development and validation of a renal risk score in ANCA-associated glomerulonephritis.

Authors:  Silke R Brix; Mercedes Noriega; Pierre Tennstedt; Eik Vettorazzi; Martin Busch; Martin Nitschke; Wolfram J Jabs; Fedai Özcan; Ralph Wendt; Martin Hausberg; Lorenz Sellin; Ulf Panzer; Tobias B Huber; Rüdiger Waldherr; Helmut Hopfer; Rolf A K Stahl; Thorsten Wiech
Journal:  Kidney Int       Date:  2018-10-29       Impact factor: 10.612

9.  Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis.

Authors:  Stephen P McAdoo; Nicholas Medjeral-Thomas; Seerapani Gopaluni; Anisha Tanna; Nicholas Mansfield; Jack Galliford; Megan Griffith; Jeremy Levy; Thomas D Cairns; David Jayne; Alan D Salama; Charles D Pusey
Journal:  Nephrol Dial Transplant       Date:  2019-01-01       Impact factor: 5.992
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.